Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin plus Rituximab Followed by Stem Cell Transplantation in Relapsed/Refractory DLBCL Patients: Safety and Efficacy

Nina Wagner-Johnston, Andre Goy, Maria Alma Rodriguez, Christopher Ehmann, Paul Hamlin, John Radford, Catherine Thieblemont, Cheolwon Suh, John Sweetenham, Ying Jiang, Sharon T. Sullivan, Erik R. Vandendries, Christian Gisselbrecht

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageUndefined
Pages (from-to)1169-1170
Number of pages2
Issue number21
Publication statusPublished - 18 Nov 2011

Cite this